This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.rt.com/news/522835-china-covid19-vaccines-shots/

The article has changed 3 times. There is an RSS feed of changes available.

Version 0 Version 1
China administers 279 million Covid-19 vaccines in fight against virus China administers 279 million Covid-19 vaccines in fight against virus
(4 months later)
The Chinese authorities have administered nearly 280 million vaccines, surpassing the US, in an effort to inoculate 40% of its population by the end of June.The Chinese authorities have administered nearly 280 million vaccines, surpassing the US, in an effort to inoculate 40% of its population by the end of June.
In an update on May 4, the Chinese government announced that, as of Monday, 279.05 million vaccines had been administered by the health authorities in the fight against Covid-19. The figure equates to around 19 doses per 100 people, although most individuals will require at least two shots, depending on which vaccines are being administered.In an update on May 4, the Chinese government announced that, as of Monday, 279.05 million vaccines had been administered by the health authorities in the fight against Covid-19. The figure equates to around 19 doses per 100 people, although most individuals will require at least two shots, depending on which vaccines are being administered.
China has now administered more vaccines than the US, as Beijing’s inoculation program picks up speed following reports of jab shortages. In comparison, the US, which previously occupied the top spot, has administered 246 million shots, of which more than 100 million have been second doses. The figure equates to 73 doses per 100 people. While most people in the US will require two doses, some received the Johnson & Johnson vaccine, which is administered in a one-shot regimen. China has now administered more vaccines than the US, as Beijing’s inoculation program picks up speed following reports of jab shortages. In comparison, the US, which previously occupied the top spot, has administered 246 million shots, of which more than 100 million have been second doses. The figure equates to 73 doses per 100 people. While most people in the US will require two doses, some received the Johnson & Johnson vaccine, which is administered in a one-shot regimen. 
China had been facing a shortage of supply, but in recent weeks, there has been an increase in the daily number of vaccines being administered. Data suggests that the health authorities now have greater access to vaccines, administering more than eight million jabs on April 28 – approximately double the daily average for earlier that month. China had been facing a shortage of supply, but in recent weeks, there has been an increase in the daily number of vaccines being administered. Data suggests that the health authorities now have greater access to vaccines, administering more than eight million jabs on April 28 – approximately double the daily average for earlier that month. 
In mid-April, Zheng Zhongwei, director of the Development Center for Medical Science and Technology of the National Health Commission, admitted China was battling to overcome vaccine shortages in some regions, but said domestic supply should increase in the coming months. The Global Times indicated that the government intends to vaccinate around 560 million people by the end of June, equating to approximately 40% of the population. In mid-April, Zheng Zhongwei, director of the Development Center for Medical Science and Technology of the National Health Commission, admitted China was battling to overcome vaccine shortages in some regions, but said domestic supply should increase in the coming months. The Global Times indicated that the government intends to vaccinate around 560 million people by the end of June, equating to approximately 40% of the population. 
If you like this story, share it with a friend!If you like this story, share it with a friend!
Dear readers and commenters,
We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.
Sorry for the inconvenience, and looking forward to your future comments,
RT Team.